P. Adamson

P. Adamson, B. Ozpolat, G. Lopez-Berestein, 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Emergent Radiation for Leukemic Optic Nerve Infiltration in a Child Receiving Intrathecal Methotrexate.

P. Adamson, D. Zarnow, R. Avery, 2019, Practical radiation oncology.

Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.

K. Matthay, P. Adamson, F. Balis, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reinduction Chemoimmunotherapy with Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) in Children, Adolescents and Young Adults: Results From Children's Oncology Group (COG) Study ADVL04P2

Xiaomin Lu, S. Hunger, M. Borowitz, 2011 .

Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti‐angiogenic therapy: A report from the children's oncology group phase I consortium

P. Adamson, S. Spunt, B. Widemann, 2015, Pediatric blood & cancer.

Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: A Children's Oncology Group report

P. Adamson, G. Reaman, J. Franklin, 2008, Pediatric blood & cancer.

Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101

P. Adamson, R. Murphy, F. Balis, 2004, Cancer Chemotherapy and Pharmacology.

Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates

P. Adamson, R. Murphy, C. McCully, 2001, Cancer Chemotherapy and Pharmacology.

Pertussis in a previously immunized child with human immunodeficiency virus infection.

P. Adamson, P. Pizzo, B. Meade, 1989, The Journal of pediatrics.

A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.

P. Adamson, R. Murphy, F. Balis, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer.

P. Adamson, B. Lange, F. Balis, 1995, Cancer research.

Phase II evaluation of topotecan for pediatric central nervous system tumors.

S. Sallan, P. Adamson, B. Lange, 1996, Cancer.

Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4.

M. Loh, J. Gastier-Foster, N. Heerema, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report.

P. Houghton, P. Adamson, J. Wright, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors

S. Steinberg, P. Adamson, F. Balis, 2008, Cancer Chemotherapy and Pharmacology.

A Phase I Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 21 Days Every 28 Days in Pediatric Patients with Solid Tumors

J. Maris, P. Adamson, F. Balis, 2008, Clinical Cancer Research.

A Phase I Trial of Immunocytokine HU14.18-IL2 in Children with Recurrent or Refractory Neuroblastoma and Other GD2 Positive Malignancies: A Study of the Children's Oncology Group

K. Matthay, P. Adamson, R. Seeger, 2004 .

Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.

P. Adamson, R. Murphy, F. Balis, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Bioavailability of Oral Methotrexate in Children with Inflammatory Bowel Disease

R. Baldassano, P. Adamson, B. Widemann, 2005, Journal of pediatric gastroenterology and nutrition.

Carboxypeptidase-G2 (CPDG2) and leucovorin (LV) rescue with and without addition of thymidine (Thd) for high-dose methotrexate (HDMTX) induced renal dysfunction

P. Adamson, F. Balis, B. Widemann, 2005 .

Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys.

P. Adamson, F. Balis, D. Poplack, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.

P. Adamson, F. Balis, G. Reaman, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II evaluation of topotecan for pediatric central nervous system tumors

S. Sallan, P. Adamson, B. Lange, 1996 .

Amifostine for children with medulloblastoma treated with cisplatin‐based chemotherapy

Michael Fisher, H. Shu, P. Adamson, 2004, Pediatric blood & cancer.

A sensitive and selective liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer.

J. Barrett, P. Adamson, J. Skolnik, 2007, Journal of mass spectrometry : JMS.

When Life Expectancy is Not Short Enough: A Perspective on the National Institute for Health and Care Excellence (NICE) Preliminary Guidance for Dinutuximab

P. Adamson, Julie R. Park, A. Pearson, 2016, Pediatric blood & cancer.

Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study.

M. Lim, C. Ahern, P. Adamson, 2012 .

A phase I trial of vorinostat in children with refractory solid tumors: A Children's Oncology Group Study

R. Gilbertson, P. Adamson, M. Ames, 2007 .

Unintended consequences of regulatory initiatives in childhood cancer drug development.

P. Adamson, 2013, JAMA pediatrics.

A Phase 1, Pharmacokinetic and Pharmacodynamic Study of Temozolomide in Pediatric Patients with Refractory/Recurrent Leukemia: A Children’s Oncology Group Study

Ingle, P. Adamson, H. Weiss, 2019 .

Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.

P. Adamson, H. Weiss, T. Horton, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Amphotericin B in the treatment of Candida cholecystitis.

P. Adamson, T. Walsh, P. Pizzo, 1989, The Pediatric infectious disease journal.

Population Pharmacokinetics of Fluconazole in Young Infants

D. Kaufman, J. Barrett, P. Adamson, 2008, Antimicrobial Agents and Chemotherapy.

Single-or Multiple-Dose Administration Intravenous Voriconazole in Children after Pharmacokinetics and Safety of

M. Karlsson, P. Adamson, N. Wood, 2004 .

Population Pharmacokinetics of Milrinone in Neonates with Hypoplastic Left Heart Syndrome Undergoing Stage I Reconstruction

S. Nicolson, T. Spray, J. Gaynor, 2006, Anesthesia and analgesia.

Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma.

P. Adamson, F. Balis, B. Widemann, 2008, Blood.

Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.

P. Adamson, F. Balis, B. Widemann, 2000, The Journal of pharmacology and experimental therapeutics.

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

A. Shad, M. Neely, P. Adamson, 2005, Antimicrobial Agents and Chemotherapy.

Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study.

P. Adamson, R. Murphy, F. Balis, 1991, Cancer research.

Phase I C linical T rial o f I ntrathecal T opotecan i n P atients With N eoplastic M eningitis

K. Matthay, P. Adamson, F. Balis, 2003 .

Anti-angiogenic agents for the treatment of brain tumors.

P. Adamson, M. Fisher, 2002, Neuroimaging clinics of North America.

Declining childhood and adolescent cancer mortality

S. Altekruse, P. Adamson, G. Reaman, 2014, Cancer.

Liquid chromatography-electrospray mass spectrometry (LC-MS) method for determination of esmolol concentration in human plasma.

A. Zuppa, P. Adamson, Heng Shi, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.

R. Hermann, P. Adamson, F. Balis, 2004, Journal of the National Cancer Institute.

Sporadic Adenocarcinoma of the Colon in Children: Case Series and Review of the Literature

R. Markowitz, P. Adamson, S. Kramer, 2012, Journal of pediatric hematology/oncology.

Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.

P. Adamson, R. Murphy, F. Balis, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells.

P. Adamson, R. Murphy, F. Balis, 1993, Biochemical pharmacology.

A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion.

P. Adamson, F. Balis, D. Poplack, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

New policies to address the global burden of childhood cancers.

E. Steliarova-Foucher, G. Vassal, M. Valsecchi, 2013, The Lancet. Oncology.

Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia.

G. Chrousos, P. Adamson, T. Kino, 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Variability in the oral bioavailability of all-trans-retinoic acid.

P. Adamson, H. Pitot, R. Murphy, 1993, Journal of the National Cancer Institute.

Acute pancreatitis after ifosfamide therapy

P. Adamson, S. Izraeli, F. Balis, 1994, Cancer.

Testing of new agents in childhood cancer preclinical models: meeting summary.

H. Fine, M. Israel, J. Maris, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase 1/2 Trial of Vorinostat and Radiation and Maintenance Vorinostat in Children with Diffuse Intrinsic Pontine Glioma: A Children's Oncology Group Report.

P. Adamson, A. Buxton, A. Gajjar, 2021, Neuro-oncology.

Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.

Soma Das, P. Adamson, Zhengjia Chen, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children’s Oncology Group phase 1 consortium study (ADVL1212)

K. Wilner, P. Adamson, F. Balis, 2020, Cancer Chemotherapy and Pharmacology.

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

M. Lim, K. Wilner, P. Adamson, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

J. Maris, M. Lim, K. Wilner, 2013, The Lancet. Oncology.

Early Phase Pediatric Cancer Trials: Progress Highlights Challenges.

P. Adamson, 2020, The oncologist.

Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

S. Armstrong, M. Rivera, K. Stegmaier, 2020, European journal of cancer.

Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study.

Mark D Krailo, Marta Hamilton, J. Dancey, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Shortening the timeline of pediatric phase I trials: the rolling six design.

Jeffrey S Barrett, Bhuvana Jayaraman, J. Barrett, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tyrosine Kinase Inhibitors in Pediatric Malignancies

P. Adamson, J. Skolnik, 2007, Cancer investigation.

Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases.

E. Hsiao, D. Teachey, P. Adamson, 2017, Bone.

Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial

M. Lim, P. Adamson, T. Laetsch, 2017, Journal of the National Cancer Institute.

Challenges and opportunities in childhood cancer drug development

R. Norris, P. Adamson, Robin E. Norris, 2012, Nature Reviews Cancer.

New Drug Development for Children with Cancer

P. Adamson, 2010 .

Reply to N.-K.V. Cheung et al.

J. Maris, K. Matthay, P. Adamson, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New drugs for children and adolescents with cancer: the need for novel development pathways.

G. Vassal, P. Adamson, C. Zwaan, 2013, The Lancet. Oncology.

Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)

K. Wilner, P. Adamson, F. Balis, 2021, Clinical Cancer Research.

Evaluation of the Retinoids With Cisplatin and Vincristine in Xenograft Models of Neuroblastoma

R. Norris, P. Adamson, V. Nguyen, 2014, Journal of pediatric hematology/oncology.

Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report.

R. Gilbertson, P. Adamson, J. Reid, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.

D. Hirtz, S. Shinnar, A. Cnaan, 2010, The New England journal of medicine.

A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer

J. Barrett, P. Adamson, J. Skolnik, 2006, Cancer Chemotherapy and Pharmacology.

Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium study

Marvin D Nelson, P. Adamson, J. Perentesis, 2010, Pediatric blood & cancer.

Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: A children's oncology group study

D. Neuberg, D. Finkelstein, P. Adamson, 2010, Pediatric blood & cancer.

Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors

A. Jimeno, M. Hidalgo, P. Adamson, 2007, Pediatric blood & cancer.

Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task Force

P. Adamson, N. Winick, F. Balis, 2017, Pediatric blood & cancer.

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

P. Meltzer, J. Trent, E. Kleinerman, 2014, Clinical Cancer Research.

Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors

R. Norris, P. Adamson, E. Fox, 2014, Pediatric blood & cancer.

Insights into pediatric rhabdomyosarcoma research: Challenges and goals

S. Tapscott, J. Khan, C. Antonescu, 2019, Pediatric blood & cancer.

Quantification of Serum Fentanyl Concentrations from Umbilical Cord Blood During Ex Utero Intrapartum Therapy

C. D. Kurth, P. Adamson, L. Maxwell, 2012, Anesthesia and analgesia.

A phase I trial and pharmacokinetic (PK) study of vorinostat (SAHA) in combination with 13 cis-retinoic acid (13cRA) in children with refractory neuroblastomas, medulloblastomas, primitive neuroectodermal tumors (PNETs), and atypical teratoid rhabdoid tumor

R. Gilbertson, P. Adamson, M. Ames, 2008 .

Phase II Trial of Ixabepilone Administered Daily for Five Days in Children and Young Adults with Refractory Solid Tumors: A Report from the Children's Oncology Group

P. Adamson, F. Balis, B. Widemann, 2010, Clinical Cancer Research.

Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2.

P. Adamson, F. Balis, T. Walsh, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report

S. Baruchel, P. Adamson, F. Balis, 2012, Clinical Cancer Research.

Phase I study of sorafenib in children with refractory solid tumors: A Children's Oncology Group Phase I Consortium trial.

S. Baruchel, P. Adamson, F. Balis, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characteristics and outcome of pediatric patients enrolled in phase I oncology trials.

P. Adamson, F. Balis, B. Widemann, 2008, The oncologist.

Imaging in childhood cancer: A society for pediatric radiology and children's oncology group joint task force report

P. Adamson, S. Kaste, M. Siegel, 2013, Pediatric blood & cancer.

The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial.

S. Nicolson, F. McGowan, P. Adamson, 2008, The Journal of thoracic and cardiovascular surgery.

Walter M Stadler, Mark J Ratain, Thomas R Fleming, 2008, European journal of cancer.

A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: A Children's Oncology Group study

P. Adamson, Zhengjia Chen, M. Bernstein, 2008, Pediatric blood & cancer.

A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study

P. Adamson, A. Pappo, M. Bernstein, 2008, Pediatric blood & cancer.

A Phase 1 Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 7 Days Every 21 Days in Pediatric Patients with Solid Tumors

Steve Y. Cho, J. Maris, P. Adamson, 2006, Clinical Cancer Research.

Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children’s Oncology Group

A. Seif, T. Alonzo, R. Gerbing, 2017, Haematologica.

Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children’s Oncology Group study

S. Baruchel, C. Ahern, P. Adamson, 2012, Cancer Chemotherapy and Pharmacology.

Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study

S. Baruchel, C. Ahern, P. Adamson, 2011, Clinical Cancer Research.

Pediatric phase I trials in oncology: an analysis of study conduct efficiency.

P. Adamson, Peter C Adamson, J. Skolnik, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improving the outcome for children with cancer: Development of targeted new agents

P. Adamson, 2015, CA: a cancer journal for clinicians.

Proton Magnet ic Resonance Spectroscopic Imaging in Chi ldren With Recurrent Primary Brain Tumors

J. Frank, B. Lewis, P. Adamson, 2000 .

Population Pharmacokinetics of Dexmedetomidine in Infants After Open Heart Surgery

S. Nicolson, J. Barrett, A. Zuppa, 2010, Anesthesia and analgesia.

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Laura A. Levit, M. Gönen, Laura A Levit, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ACCELERATE - Five years accelerating cancer drug development for children and adolescents.

P. Kearns, G. Vassal, P. Adamson, 2022, European journal of cancer.

Recommendations for the return of research results to study participants and guardians: a report from the Children's Oncology Group.

P. Adamson, S. Joffe, G. Reaman, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of targetable molecular alterations in the NCI-COG Pediatric MATCH trial.

J. Gastier-Foster, T. Alonzo, M. Mooney, 2019, Journal of Clinical Oncology.

High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma

A. Craft, P. Adamson, S. Bielack, 2004, Cancer.

Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate reader.

P. Adamson, F. Balis, B. Widemann, 1999, Clinical chemistry.

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months

D. Hirtz, S. Shinnar, A. Cnaan, 2013, Epilepsia.

Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.

C. Bult, P. Meltzer, P. Sorensen, 2016, Cancer genetics.

Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.

P. Adamson, F. Balis, C. Arndt, 1992, Cancer research.

Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.

P. Adamson, R. Murphy, R. Bukowski, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors

J. Maris, P. Adamson, F. Balis, 2009, Cancer Chemotherapy and Pharmacology.

Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: A Children's Oncology Group trial (P9962)

P. Adamson, M. Krailo, S. Berg, 2012, Pediatric blood & cancer.

Imaging in early phase childhood cancer trials

P. Adamson, 2009, Pediatric Radiology.

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.

Helen X. Chen, C. Ahern, P. Adamson, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study.

M. Mehta, T. Zhou, I. Pollack, 2008, Neuro-oncology.

Topotecan by 21‐day continuous infusion in children with relapsed or refractory solid tumors: A Children's Oncology Group study

P. Adamson, D. Hawkins, J. Whitlock, 2006, Pediatric blood & cancer.

Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.

P. Adamson, R. Murphy, F. Balis, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia

S. Steinberg, P. Adamson, F. Balis, 2004, Cancer Chemotherapy and Pharmacology.

Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.

P. Adamson, F. Balis, C. Arndt, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy‐induced anemia

P. Adamson, J. Blumer, C. Hastings, 2007, Pediatric blood & cancer.

Drug discovery in paediatric oncology: roadblocks to progress

P. Houghton, P. Adamson, K. Pritchard-Jones, 2014, Nature Reviews Clinical Oncology.

Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2.

M. Patterson, P. Adamson, B. Widemann, 1996, Mayo Clinic proceedings.

Carboxypeptidase‐G2 rescue in a patient with high dose methotrexate‐induced nephrotoxicity

P. Adamson, R. Murphy, F. Balis, 1995, Cancer.

Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report

P. Adamson, C. Lau, Xiao-Nan Li, 2010, Clinical Cancer Research.

Approaches to Clear Residual Chemotherapeutics From Indwelling Catheters in Children With Cancer

J. Barrett, P. Adamson, J. Skolnik, 2010, Therapeutic drug monitoring.

Dexrazoxane for reducing anthracycline-related cardiotoxicity in children with cancer: An update of the evidence

S. Sallan, S. Swain, S. Lipshultz, 2014 .

A Phase I Trial and Pharmacokinetic Study of Aflibercept (VEGF Trap) in Children with Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report

S. Baruchel, A. Chen, C. Ahern, 2012, Clinical Cancer Research.

Reply to P.A. Meyers et al

P. Adamson, B. Widemann, 2011 .

Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer

P. Adamson, F. Balis, R. Packer, 2003, Cancer Chemotherapy and Pharmacology.

Anticancer effects of fenretinide in human medulloblastoma.

P. Adamson, M. Vemuri, Asha Guttapalli, 2006, Cancer letters.

Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias

R. Norris, P. Adamson, 2010, Cancer Chemotherapy and Pharmacology.

The importance of pharmacokinetic limited sampling models for childhood cancer drug development.

P. Adamson, J. Panetta, L. Iacono, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pretreatment EEG in childhood absence epilepsy

E. Mizrahi, D. Hirtz, S. Shinnar, 2013, Neurology.

Principles and Practice of Pediatric Oncology (7th ed.)

P. Adamson, L. Helman, D. Poplack, 2015 .

Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.

P. Adamson, P. Adamson, 1994, Leukemia.

A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.

S. Baruchel, P. Adamson, A. Pappo, 2012, European journal of cancer.

Study of ABT-751 , an Orally BioavailableTubulin Inhibitor , Administered Daily for 21 Days Every 28 Days in Pediatric Patients with SolidTumors

J. Maris, P. Adamson, F. Balis, 2008 .

A Phase 1Study of ABT-751, an Orally BioavailableTubulin Inhibitor, Administered Daily for 7 Days Every 21Days in Pediatric Patients with Solid Tumors

J. Maris, P. Adamson, F. Balis, 2006 .

Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study.

P. Adamson, M. Hogarty, M. Krailo, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New approaches to drug development in pediatric oncology.

P. Adamson, S. Blaney, 2005, Cancer journal.

A Phase I Study of 17-Allylaminogeldanamycin in Relapsed/Refractory Pediatric Patients with Solid Tumors: A Children's Oncology Group Study

R. Gilbertson, J. Neglia, P. Adamson, 2007, Clinical Cancer Research.

Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study

P. Adamson, R. Murphy, F. Balis, 2001, Cancer Chemotherapy and Pharmacology.

Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study

P. Adamson, M. Ames, R. Gorlick, 2013, Pediatric blood & cancer.

Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2

Xiaomin Lu, S. Hunger, M. Borowitz, 2015, Pediatric blood & cancer.

The Children’s Oncology Group: Organizational Structure, Membership, and Institutional Characteristics

T. Alonzo, P. Adamson, Janice S. Withycombe, 2018, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

The Children's Oncology Group Childhood Cancer Research Network (CCRN): Case catchment in the United States

P. Adamson, G. Reaman, J. Ross, 2014, Cancer.

CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine!

H. Hakonarson, P. Adamson, Jin Li, 2016, Anesthesiology.

Study of 17-Allylaminogeldanamycin in Relapsed / Refractory Pediatric Patients with SolidTumors : AChildren ’ s Oncology Group Study

R. Gilbertson, J. Neglia, P. Adamson, 2007 .

A phase I trial and pharmacokinetic study of IMC-A12 in pediatric patients with relapsed/refractory solid tumors: A Children's Oncology Group Phase I Consortium study.

C. Ahern, C. Roberts, P. Adamson, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial and pharmacokinetic (PK) study of ABT-751, an orally bioavailable tubulin binding agent, in pediatric patients with refractory solid tumors.

J. Maris, G. Gordon, P. Adamson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second monotherapy in childhood absence epilepsy

D. Hirtz, S. Shinnar, A. Cnaan, 2017, Neurology.

The impact of chemotherapy shortages on COG and local clinical trials: A report from the Children's Oncology Group

P. Adamson, R. Aplenc, Yimei Li, 2015, Pediatric blood & cancer.

Challenges in drug development for children.

P. Adamson, 2017, Clinical advances in hematology & oncology : H&O.

Phase I study of pazopanib in children with relapsed or refractory solid tumors (ADVL0815): A Children's Oncology Group Phase I Consortium Trial.

S. Baruchel, C. Ahern, P. Adamson, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetics of mercaptopurine in children with acute lymphocytic leukemia.

S. Steinberg, P. Adamson, F. Balis, 1990, The New England journal of medicine.

Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors

N. Patronas, P. Adamson, F. Balis, 2001, Cancer Chemotherapy and Pharmacology.

THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DEXMEDETOMIDINE IN INFANTS FOLLOWING OPEN HEART SURGERY.: 23

S. Nicolson, J. Barrett, A. Zuppa, 2005 .

New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics: A Review

A. Lo, P. Adamson, R. Rousseau, 2018, JAMA oncology.

Preclinical evaluation of pemetrexed in pediatric solid tumors

E. Rappaport, R. Norris, P. Adamson, 2011, Pediatric blood & cancer.

Reaffirming and Clarifying the American Society of Clinical Oncology’s Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment

Laura A. Levit, M. Gönen, A. Dicker, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose Intensification Improves the Outcome of Ewing Sarcoma.

P. Adamson, K. Janeway, R. Gorlick, 2018, Journal of Clinical Oncology.

Developing drugs for pediatric malignancies.

P. Adamson, 2013, Clinical advances in hematology & oncology : H&O.

#672 Oral 6‐thioguanine (TG) causes relatively mild and reversible hepatic venoocclusive disease (VOD)

H. Sather, P. Adamson, P. Gaynon, 1998 .

A phase II study of Campath‐1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report

A. Angiolillo, P. Adamson, G. Reaman, 2009, Pediatric blood & cancer.

Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group

Helen X. Chen, P. Adamson, J. Reid, 2014, Pediatric blood & cancer.

Pediatric phase I trial and pharmacokinetic (PK) study of dasatinib: A report from the Children's Oncology Group

P. Adamson, J. Wright, S. Shusterman, 2007 .

Untying the Gordian knot.

A. Zuppa, P. Adamson, F. Su, 2007, Anesthesia and analgesia.

Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: A report from the Children's Oncology Group

R. Arceci, P. Adamson, F. Balis, 2011, Pediatric blood & cancer.

A liquid chromatography/tandem mass spectrometry method for determination of obatoclax in human plasma.

R. Norris, P. Adamson, G. Moorthy, 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Lessons Learned from the Investigational Device Exemption Review of Children's Oncology Group Trial AAML1031

S. Meshinchi, S. Hunger, P. Adamson, 2012, Clinical Cancer Research.

K. Norga, D. Faller, G. Vassal, 2020, European journal of cancer.

Abundant anti‐apoptotic BCL‐2 is a molecular target in leukaemias with t(4;11) translocation

C. Felix, C. Willman, J. Barrett, 2008, British journal of haematology.

A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.

S. Baruchel, P. Adamson, A. Pappo, 2012, European journal of cancer.

Model‐Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy

S. Shinnar, A. Cnaan, P. Adamson, 2023, Clinical pharmacology and therapeutics.

Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia.

P. Adamson, 1994, Seminars in hematology.

Dose-dependent pharmacokinetics of all-trans-retinoic acid.

P. Adamson, R. Murphy, F. Balis, 1992, Journal of the National Cancer Institute.